The initial morphologic lesion in chronic hepatitis, important or unimportant?

Hepatology

Volumn 6, Issue 3, 1986, Pages 518-522

  Combes, Burton ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; STEROID;

ARTICLE; CHRONIC HEPATITIS; HUMAN; IMMUNOLOGY; LIVER; NECROSIS; PATHOLOGY; PROBABILITY; PROGNOSIS;

HEPATITIS B SURFACE ANTIGENS; HEPATITIS, CHRONIC; HUMAN; LIVER; NECROSIS; PROBABILITY; PROGNOSIS; STEROIDS;

EID: 0022721741     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840060332     Document Type: Editorial

References (23)

1. The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis
2. Clinical assessment of cirrhosis in severe chronic active liver disease. Specificity and sensitivity of physical and laboratory findings
3. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy
4. Sampling variability on percutaneous liver biopsy
5. Liver biopsy in chronic aggresive hepatitis. Diagnostic reproducibility in relation to size of specimen
6. Controlled trial of corticosteroid therapy in active chronic hepatitis
7. Controlled trial of prednisone and azathioprine in active chronic hepatitis
8. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatment and early prognosis
9. A classification of chronic hepatitis
10. Prognosis of chronic persistent hepatitis
11. Chronic active liver disease. The range of histologic lesions, their response to treatment, and evaluation
12. Acute and chronic hepatitis revisited
13. Treatment of chronic active hepatitis. An analysis of three controlled trials
14. Severe chronic active liver disease. Prognostic significance of initial morphologic patterns
15. Development and prognosis of histologic cirrhosis in corticosteroid‐treated hepatitis B surface antigen‐negative chronic active hepatitis
16. The prognosis of chronic aggressive hepatitis
17. Chronic active hepatitis. Aetiological considerations based on clinical and serological studies
18. Long‐term follow‐up of chronic active hepatitis of moderate severity
19. Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis B s antigen
20. Deleterious effect of prednisolone in HBsAg‐positive chronic hepatitis
21. Prednisolone in HBsAg‐positive chronic active hepatitis. Histologic evaluation in a controlled prospective study
22. The detrimental effects of adrenocorticosteroid therapy in HBsAg‐positive chronic active hepatitis: fact or artifact?
23. Prognostic significance of bridging necrosis in chronic active hepatitis